drugset / Trial / NCT02237534
Lanthanum Versus Calcium Carbonate for Vascular Abnormalities in Patients With CKD and Hyperphosphatemia
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to compare the effect of lanthanum carbonate and calcium carbonate on the progression of coronary calcification and vascular endothelial dysfunction.
Timeline
- Start
- 2014-09
- Primary completion
- 2023-03-31
- Completion
- 2023-09
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Comparator | Calcium carbonate | Other / unclassified | 1500 mg | — |
| Subject | Lanthanum Carbonate | Other / unclassified | 750 mg | — |